SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-107676
Filing Date
2017-04-03
Accepted
2017-04-03 08:00:56
Documents
7
Period of Report
2017-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d372036d8k.htm 8-K 18748
2 EX-10.1 d372036dex101.htm EX-10.1 34373
3 EX-99.1 d372036dex991.htm EX-99.1 8289
4 GRAPHIC g372036ex101pg6a.jpg GRAPHIC 11521
5 GRAPHIC g372036ex101pg6b.jpg GRAPHIC 12885
6 GRAPHIC g372036logo1.jpg GRAPHIC 5626
7 GRAPHIC g372036logo2.jpg GRAPHIC 3066
  Complete submission text file 0001193125-17-107676.txt   108903
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 17732327
SIC: 2834 Pharmaceutical Preparations